pioglitazone has been researched along with Brain Hemorrhage, Cerebral in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Excerpt | Relevance | Reference |
---|---|---|
"Hyperglycemia was induced by streptozotocin treatment." | 1.42 | Hyperglycemia and PPARĪ³ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic Stroke. ( Gliem, M; Hartung, HP; Jander, S; Klotz, L; van Rooijen, N, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gliem, M | 1 |
Klotz, L | 1 |
van Rooijen, N | 1 |
Hartung, HP | 1 |
Jander, S | 1 |
Gonzales, NR | 1 |
Shah, J | 1 |
Sangha, N | 1 |
Sosa, L | 1 |
Martinez, R | 1 |
Shen, L | 1 |
Kasam, M | 1 |
Morales, MM | 1 |
Hossain, MM | 1 |
Barreto, AD | 1 |
Savitz, SI | 1 |
Lopez, G | 1 |
Misra, V | 1 |
Wu, TC | 1 |
El Khoury, R | 1 |
Sarraj, A | 1 |
Sahota, P | 1 |
Hicks, W | 1 |
Acosta, I | 1 |
Sline, MR | 1 |
Rahbar, MH | 1 |
Zhao, X | 1 |
Aronowski, J | 1 |
Grotta, JC | 1 |
1 trial available for pioglitazone and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Dose-Response Relationship, Drug; D | 2013 |
1 other study available for pioglitazone and Brain Hemorrhage, Cerebral
Article | Year |
---|---|
Hyperglycemia and PPARĪ³ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic Stroke.
Topics: Animals; Anticoagulants; Cell Polarity; Cerebral Hemorrhage; Diabetes Mellitus, Experimental; Diseas | 2015 |